In Vivo Osteoarthritis Target Validation Utilizing Genetically-Modified Mice

E-ISSN： 1873-5592|8|2|367-376

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.2, 2007-02, pp. : 367-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetically Modified Mice in Neuropharmacology

By Brusa R.

Pharmacological Research, Vol. 39, Iss. 6, 1999-06 ,pp. : 405-419

Academic Press

Access to resources Recommend Favorite

Validation of GABAA Receptor Subtypes as Potential Drug Targets by Using Genetically Modified Mice

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 4, 2003-08 ,pp. : 207-212

Bentham Science Publishers

Access to resources Recommend Favorite

Genetically Modified Mice Models for Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 6, 2006-01 ,pp. : 609-627

Bentham Science Publishers

Access to resources Recommend Favorite

Pathology and Development - Developmental Systems for Target Validation and Drug Screening in Osteoarthritis

Drug Design Reviews - Online, Vol. 2, Iss. 6, 2005-09 ,pp. : 435-448

Bentham Science Publishers

Access to resources Recommend Favorite

Genetically Modified Mice as Tools to Understand the Neurobiological Substrates of Depression

Current Pharmaceutical Design, Vol. 20, Iss. 23, 2014-05 ,pp. : 3718-3737

Bentham Science Publishers

Access to resources Recommend Favorite